{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:38:45Z","timestamp":1792024725591,"version":"4.4.0"},"reference-count":161,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.addr.2023.114967","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T19:26:44Z","timestamp":1687030004000},"page":"114967","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Antifungal therapy: Novel drug delivery strategies driven by new targets"],"prefix":"10.1016","volume":"199","author":[{"given":"Shuang","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiqi","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongbao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2023.114967_b0005","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3390\/jof3040057","article-title":"Global and multi-national prevalence of fungal diseases\u2014estimate precision","volume":"3","author":"Bongomin","year":"2017","journal-title":"J. Fungi"},{"key":"10.1016\/j.addr.2023.114967_b0010","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fmicb.2019.00214","article-title":"The still underestimated problem of fungal diseases worldwide","volume":"10","author":"Almeida","year":"2019","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0015","doi-asserted-by":"crossref","unstructured":"A. Arastehfar, T. Gabald\u00f3n, R. Garcia-Rubio, J.D. Jenks, M. Hoenigl, H.J.F. Salzer, M. Ilkit, C. Lass-Fl\u00f6rl, D.S. Perlin, Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium, Antibiot. (Basel, Switzerland). 9 (2020) 1\u201329, doi: 10.3390\/ANTIBIOTICS9120877.","DOI":"10.3390\/antibiotics9120877"},{"key":"10.1016\/j.addr.2023.114967_b0020","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004404","article-title":"Hidden killers: human fungal infections","volume":"4","author":"Brown","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2023.114967_b0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a019703","article-title":"Antifungal drug development: challenges, unmet clinical needs, and new approaches","volume":"4","author":"Roemer","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.addr.2023.114967_b0030","doi-asserted-by":"crossref","unstructured":"M. Ghannoum, M.C. Arendrup, V.P. Chaturvedi, S.R. Lockhart, T.S. McCormick, S. Chaturvedi, E.L. Berkow, D. Juneja, B. Tarai, N. Azie, D. Angulo, T.J. Walsh, Ibrexafungerp: a novel oral triterpenoid antifungal in development for the treatment of Candida auris infections, Antibiot. (Basel, Switzerland). 9 (2020) 1\u201313, doi: 10.3390\/ANTIBIOTICS9090539.","DOI":"10.3390\/antibiotics9090539"},{"key":"10.1016\/j.addr.2023.114967_b0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1011322","article-title":"Advances in the treatment of invasive fungal disease","volume":"19","author":"Zhang","year":"2023","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.addr.2023.114967_b0040","doi-asserted-by":"crossref","unstructured":"P. Pappas, B.J. Kullberg, J.A. Vazquez, I. Oren, G. Rahav, M. Aoun, P. Bulpa, R. Ben-Ami, R. Ferrer, T.P. McCarty, G.R.T. III, S. Barbat, P. Wedel, I. Oborska, H.T. Schlamm, M. Hodges, 147. Clinical safety and efficacy of novel antifungal, fosmanogepix, in: The Treatment of Candidemia: Results from a Phase 2 Proof of Concept Trial, Open Forum Infect. Dis. 7 (2020) S203, doi: 10.1093\/OFID\/OFAA439.457.","DOI":"10.1093\/ofid\/ofaa439.457"},{"key":"10.1016\/j.addr.2023.114967_b0045","first-page":"1","article-title":"The antifungal pipeline for invasive fungal diseases: what does the future hold?","author":"Neoh","year":"2023","journal-title":"Expert Rev. Anti Infect. Ther."},{"key":"10.1016\/j.addr.2023.114967_b0050","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s40265-021-01611-0","article-title":"The antifungal pipeline: fosmanogepix, ibrexafungerp, olorofim, opelconazole, and rezafungin","volume":"81","author":"Hoenigl","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2023.114967_b0055","doi-asserted-by":"crossref","unstructured":"G.R. Thompson, A. Soriano, O.A. Cornely, B.J. Kullberg, M. Kollef, J. Vazquez, P.M. Honore, M. Bassetti, J. Pullman, M. Chayakulkeeree, I. Poromanski, C. Dignani, A.F. Das, T. Sandison, P.G. Pappas, M. Akova, R. AlAgha, G. Alangaden, S.J. Albrecht, B. Alexander, M. Al-Obaidi, G. Ambasch, F. Armestar Rodriguez, A. Azap, A. Baffoe-Bonnie, L. Belkhir, R. Ben-Ami, D. Boutoille, A. Cascio, L.Y. Chai, R. Chaiwarith, S. Chen, Y.C. Chen, Y.H. Chen, J.Y. Choi, Y.H. Choi, D. Chotiprasitsakul, J.W. Chung, F. Danion, B. Denis, E. Diaz Santos, M.O. Dictar, M. Diltoer, H. Dupont, S. Feng, M.A. Ferre Colomer, R. Ferrer, J.M.F.R. Forel, J. Fort\u00fan-Abete, J. Garcia-Diaz, M. Girardis, F. He, M. Hites, M.W. Ho, P. Honore, J.P. Horcajada Gallego, H. Huang, P.Y. Huang, Y. Huang, O. Hussein, P. Intalapaporn, S. Jaruratanasirikul, L. Jauregui-Peredo, M. Johnson, D.S. Jung, K. Jutivorakool, W. V. Kern, D.H. Kett, T. Khawcharoenporn, Y.K. Kim, P. Koehler, A. Kotanidou, A. Lachiewicz, Q. Lin, L.E. Lopez Cortes, H. Luo, R. Luzzati, Y. Maor, T. McCarty, M. Merelli, P. Merino Amador, J. Midturi, G.M. Migliorino, J.P. Mira, P. Mootsikapun, O. Morrissey, P. Munoz Garcia de Paredes, C. Mussini, E. Mylonakis, S. Nseir, W. Nseir, Z. Odabasi, V. Papastamopoulos, D. Paterson, T.F. Patterson, K.R. Peck, Z. Peng, N. Permpalung, G.J. Plantefeve, I.G. Poromanski, D. Powell, M. Psichogiou, S.H. Puah, G. Rahav, A.R. Martinez, J.C. Ramos Ramos, A. Raz-Pasteur, C.A. Restrepo Castro, F. Riera, F. Roblot, R.J. Rodriguez Alvarez, B. Rogers, E. Roilides, G. Sanchez Vallejo, G. Sganga, N. Sipsas, M. Slavin, A. Spec, J. Strahilevitz, D.M. Tancheva, Z. Tao, D. Teschner, E. Van Wijngaerden, P. Vergidis, P. Viale, F. Der Wang, S. Wang, G. Weber, J. Weng, J. Xu, L. Yao, S. Yavuz, M. Yilmaz, J.A. Young, A.H. Zarate, J. Zeng, Y. Zhang, Rezafungin versus caspofungin for treatment of candidaemia and invasive candidiasis (ReSTORE): a multicentre, double-blind, double-dummy, randomised phase 3 trial, Lancet 401 (2023) 49\u201359, doi: 10.1016\/S0140-6736(22)02324-8.","DOI":"10.1016\/S0140-6736(22)02324-8"},{"key":"10.1016\/j.addr.2023.114967_b0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/s41578-020-00269-6","article-title":"Targeted drug delivery strategies for precision medicines","volume":"6","author":"Manzari","year":"2021","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0065","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202111344","article-title":"Augmenting the precise targeting of antimicrobial peptides (AMPs) and AMP-based drug delivery via affinity-filtering strategy","volume":"32","author":"Tang","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0070","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1021\/acs.nanolett.8b02229","article-title":"Nanoparticles targeted against cryptococcal pneumonia by interactions between chitosan and its peptide ligand","volume":"18","author":"Tang","year":"2018","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2023.114967_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.119002","article-title":"Borneol and poly (ethylene glycol) dual modified BSA nanoparticles as an itraconazole vehicle for brain targeting","volume":"575","author":"Zhang","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.114967_b0080","doi-asserted-by":"crossref","first-page":"10096","DOI":"10.1016\/j.apsusc.2011.06.145","article-title":"Light-induced antifungal activity of TiO2 nanoparticles\/ZnO nanowires","volume":"257","author":"Haghighi","year":"2011","journal-title":"Appl. Surf. Sci."},{"key":"10.1016\/j.addr.2023.114967_b0085","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1021\/acsnano.8b09681","article-title":"Oriented assembly of cell-mimicking nanoparticles via a molecular affinity strategy for targeted drug delivery","volume":"13","author":"Xie","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2023.114967_b0090","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.bmcl.2011.12.051","article-title":"Novel dendrimeric lipopeptides with antifungal activity","volume":"22","author":"Janiszewska","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.addr.2023.114967_b0095","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.3389\/fmicb.2019.02993","article-title":"The fungal cell wall: Candida, Cryptococcus, and Aspergillus species","volume":"10","author":"Garcia-Rubio","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fmicb.2017.00092","article-title":"Regulation of sterol biosynthesis in the human fungal pathogen Aspergillus fumigatus: opportunities for therapeutic development","volume":"8","author":"Dhingra","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0105","first-page":"e00025","article-title":"Dectin-1-targeted antifungal liposomes exhibit enhanced efficacy","volume":"4","author":"Ambati","year":"2019","journal-title":"MSphere."},{"key":"10.1016\/j.addr.2023.114967_b0110","article-title":"Dectin-2-targeted antifungal liposomes exhibit enhanced efficacy","volume":"4","author":"Ambati","year":"2019","journal-title":"MSphere."},{"key":"10.1016\/j.addr.2023.114967_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00030-21","article-title":"Antifungal liposomes directed by dectin-2 offer a promising therapeutic option for pulmonary Aspergillosis","volume":"12","author":"Ambati","year":"2021","journal-title":"MBio"},{"key":"10.1016\/j.addr.2023.114967_b0120","doi-asserted-by":"crossref","first-page":"28553","DOI":"10.1074\/jbc.M300680200","article-title":"Candida albicans Ssa1\/2p is the cell envelope binding protein for human salivary histatin 5","volume":"278","author":"Li","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.114967_b0125","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jconrel.2017.04.023","article-title":"Targeting and synergistic action of an antifungal peptide in an antibiotic drug-delivery system","volume":"256","author":"Park","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114967_b0130","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1128\/IAI.01840-06","article-title":"Fungicidal monoclonal antibody C7 binds to Candida albicans Als 3","volume":"75","author":"Brena","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2023.114967_b0135","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.2147\/IJN.S150648","article-title":"Silver nanoparticles induced alterations in multiple cellular targets, which are critical for drug susceptibilities and pathogenicity in fungal pathogen (Candida albicans)","volume":"13","author":"Radhakrishnan","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114967_b0140","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1166\/jnn.2016.10934","article-title":"Synergy between polyvinylpyrrolidone-coated silver nanoparticles and azole antifungal against drug-resistant Candida albicans","volume":"16","author":"Sun","year":"2016","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.addr.2023.114967_b0145","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181e9441b","article-title":"Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis","volume":"89","author":"Safdar","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.addr.2023.114967_b0150","doi-asserted-by":"crossref","unstructured":"N.R.H. Stone, T. Bicanic, R. Salim, W. Hope, Liposomal amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions, Drugs 76 (2016) 485\u2013500, doi: 10.1007\/S40265-016-0538-7.","DOI":"10.1007\/s40265-016-0538-7"},{"key":"10.1016\/j.addr.2023.114967_b0155","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/AAC.04723-14","article-title":"Pharmacodynamics of amphotericin B deoxycholate, amphotericin B lipid complex, and liposomal amphotericin B against Aspergillus fumigatus","volume":"59","author":"Al-Nakeeb","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114967_b0160","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1128\/AAC.48.12.4808-4812.2004","article-title":"Liposomal nystatin in patients with invasive aspergillosis refractory to or intolerant of amphotericin B","volume":"48","author":"Offner","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114967_b0165","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.2217\/nnm-2020-0324","article-title":"Rod-shaped gold nanoparticles exert potent candidacidal activity and decrease the adhesion of fungal cells","volume":"15","author":"Piktel","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2023.114967_b0170","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.2147\/IJN.S140661","article-title":"Use of magnetic nanoparticles as a drug delivery system to improve chlorhexidine antimicrobial activity","volume":"12","author":"Tokajuk","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114967_b0175","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.1002\/anie.201802509","article-title":"Localizing antifungal drugs to the correct organelle can markedly enhance their efficacy","volume":"57","author":"Benhamou","year":"2018","journal-title":"Angew. Chemie Int. Ed."},{"key":"10.1016\/j.addr.2023.114967_b0180","doi-asserted-by":"crossref","unstructured":"K. G\u00f3ralska, J. Blaszkowska, M. Dzikowiec, Neuroinfections caused by fungi, Infect. 46 (2018) 443\u2013459, doi: 10.1007\/S15010-018-1152-2.","DOI":"10.1007\/s15010-018-1152-2"},{"key":"10.1016\/j.addr.2023.114967_b0185","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3390\/molecules23061289","article-title":"Strategies for Enhancing the Permeation of CNS-Active Drugs through the Blood-Brain Barrier: A Review","volume":"23","author":"Zeiadeh","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2023.114967_b0190","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0169-409X(03)00100-5","article-title":"Pain and the blood\u2013brain barrier: obstacles to drug delivery","volume":"55","author":"Wolka","year":"2003","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114967_b0195","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/1061186031000115150","article-title":"The study on brain targeting of the amphotericin B liposomes","volume":"11","author":"Zhang","year":"2003","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2023.114967_b0200","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jconrel.2010.06.018","article-title":"Angiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brain","volume":"147","author":"Shao","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2023.114967_b0205","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejpb.2017.01.014","article-title":"Development and characterization of novel highly-loaded itraconazole poly(butyl cyanoacrylate) polymeric nanoparticles","volume":"114","author":"\u0106uri\u0107","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2023.114967_b0210","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/1061186X.2010.492523","article-title":"Targeted brain delivery of itraconazole via RVG29 anchored nanoparticles","volume":"19","author":"Chen","year":"2011","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2023.114967_b0215","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/5944518","article-title":"Characteristics of invasive pulmonary fungal diseases diagnosed by pathological examination","author":"Zhang","year":"2021","journal-title":"Can. J. Infect. Dis. Med. Microbiol. = J. Can. Des Mal. Infect. La Microbiol. M\u00e9dicale."},{"key":"10.1016\/j.addr.2023.114967_b0220","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S2213-2600(13)70072-9","article-title":"Pulmonary drug delivery: from generating aerosols to overcoming biological barriers\u2014therapeutic possibilities and technological challenges","volume":"1","author":"Ruge","year":"2013","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.addr.2023.114967_b0225","first-page":"1313","article-title":"Microencapsulation of nanoemulsions: novel Trojan particles for bioactive lipid molecule delivery","volume":"6","author":"Li","year":"2011","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2023.114967_b0230","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/IAI.73.1.622-626.2005","article-title":"Intercellular adhesion molecule 1-dependent activation of interleukin 8 expression in Candida albicans-infected human gingival epithelial cells","volume":"73","author":"Egusa","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2023.114967_b0235","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1016\/j.apsb.2021.04.023","article-title":"Nanomedicine for acute respiratory distress syndrome: the latest application, targeting strategy, and rational design","volume":"11","author":"Qiao","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2023.114967_b0240","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1186\/s12951-018-0431-5","article-title":"Anti-ICAM-1 antibody-modified nanostructured lipid carriers: a pulmonary vascular endothelium-targeted device for acute lung injury therapy","volume":"16","author":"Li","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2023.114967_b0245","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1080\/10717544.2016.1259369","article-title":"Targeting delivery of simvastatin using ICAM-1 antibody-conjugated nanostructured lipid carriers for acute lung injury therapy","volume":"24","author":"Li","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2023.114967_b0250","doi-asserted-by":"crossref","unstructured":"J. Grommes, O. Soehnlein, Contribution of neutrophils to acute lung injury, Mol. Med. 17 (2010) 293\u2013307, doi: 10.2119\/MOLMED.2010.00138.","DOI":"10.2119\/molmed.2010.00138"},{"key":"10.1016\/j.addr.2023.114967_b0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121971","article-title":"Neutrophil membrane-coated therapeutic liposomes for targeted treatment in acute lung injury","volume":"624","author":"Huang","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.114967_b0260","doi-asserted-by":"crossref","unstructured":"P.K. Mukherjee, B. Sendid, G. Hoarau, J.F. Colombel, D. Poulain, M.A. Ghannoum, Mycobiota in gastrointestinal diseases, Nat. Rev. Gastroenterol. Hepatol. 12 (2014) 77\u201387, doi: 10.1038\/nrgastro.2014.188.","DOI":"10.1038\/nrgastro.2014.188"},{"key":"10.1016\/j.addr.2023.114967_b0265","first-page":"316","article-title":"Host response to Candida albicans bloodstream infection and sepsis","volume":"6","author":"Duggan","year":"2015","journal-title":"Virulence"},{"key":"10.1016\/j.addr.2023.114967_b0270","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3748\/wjg.v20.i5.1165","article-title":"Intestinal barrier in inflammatory bowel disease","volume":"20","author":"Antoni","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.addr.2023.114967_b0275","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/1061186021000001878","article-title":"Accumulation of PEG-liposomes in the inflamed colon of rats: potential for therapeutic and diagnostic targeting of inflammatory bowel diseases","volume":"10","author":"Awasthi","year":"2002","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2023.114967_b0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024202","article-title":"Enhanced transferrin receptor expression by proinflammatory cytokines in enterocytes as a means for local delivery of drugs to inflamed gut mucosa","volume":"6","author":"Harel","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2023.114967_b0285","doi-asserted-by":"crossref","unstructured":"P. Marimuthu, A.G. Sch\u00e4tzlein, Biological barriers: transdermal, oral, mucosal, blood brain barrier, and the blood eye barrier, in: Fundam. Pharm. Nanosci., Springer New York, New York, NY, 2013, pp. 301\u2013336, doi: 10.1007\/978-1-4614-9164-4_12.","DOI":"10.1007\/978-1-4614-9164-4_12"},{"key":"10.1016\/j.addr.2023.114967_b0290","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1201\/9781003000693-9","article-title":"Panoramic view of biological barricades and their influence on polysaccharide nanoparticle transport: an updated status in cancer","author":"Sreeranganathan","year":"2020","journal-title":"Nat. Prod. Chem."},{"key":"10.1016\/j.addr.2023.114967_b0295","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1365-2141.2005.05397.x","article-title":"The immune response to fungal infections","volume":"129","author":"Shoham","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.addr.2023.114967_b0300","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12223-018-0584-5","article-title":"How much do we know about hemolytic capability of pathogenic Candida species?","volume":"63","author":"Furlaneto","year":"2018","journal-title":"Folia Microbiol. (Praha)"},{"key":"10.1016\/j.addr.2023.114967_b0305","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.3389\/fimmu.2020.01094","article-title":"The diverse roles of phagocytes during bacterial and fungal infections and sterile inflammation: lessons from zebrafish","volume":"11","author":"Linnerz","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2023.114967_b0310","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1073\/pnas.052702799","article-title":"Replication of Cryptococcus neoformans inmacrophages is accompanied by phagosomal permeabilization andaccumulation of vesicles containing polysaccharide in the cytoplasm","volume":"99","author":"Tucker","year":"2002","journal-title":"PNAS"},{"key":"10.1016\/j.addr.2023.114967_b0315","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3389\/fimmu.2020.01066","article-title":"Phagocytosis: our current understanding of a universal biological process","volume":"11","author":"Uribe-Querol","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2023.114967_b0320","doi-asserted-by":"crossref","first-page":"6175","DOI":"10.1002\/adma.201202847","article-title":"Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery","volume":"24","author":"Meng-Hua Xiong","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0325","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(00)00522-6","article-title":"Ligand directed macrophage targeting of amphotericin B loaded liposomes","volume":"210","author":"Vyas","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2023.114967_b0330","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ijbiomac.2017.11.126","article-title":"Carboxymethylated \u0269-carrageenan conjugated amphotericin B loaded gelatin nanoparticles for treating intracellular Candida glabrata infections","volume":"110","author":"Aparna","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.addr.2023.114967_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/21691401.2017.1408116","article-title":"Macrophage repolarization using CD44-targeting hyaluronic acid\u2013polylactide nanoparticles containing curcumin","volume":"46","author":"Farajzadeh","year":"2017","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"key":"10.1016\/j.addr.2023.114967_b0340","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11095-017-2293-1","article-title":"Fabrication of 3-O-sn-phosphatidyl-L-serine anchored PLGA nanoparticle bearing amphotericin B for macrophage targeting","volume":"35","author":"Singh","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2023.114967_b0345","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0169-409X(99)00061-7","article-title":"Tuftsin-bearing liposomes in treatment of macrophage-based infections","volume":"41","author":"Agrawal","year":"2000","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114967_b0350","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3390\/pharmaceutics14091932","article-title":"Antifungal encapsulated into ligand-functionalized nanoparticles with high specificity for macrophages","volume":"14","author":"Mej\u00eda","year":"2022","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.addr.2023.114967_b0355","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/920517","article-title":"Pentraxin 3(PTX 3): an endogenous modulator of the inflammatory response","volume":"2012","author":"Kunes","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.addr.2023.114967_b0360","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/imr.12476","article-title":"Pentraxins in the activation and regulation of innate immunity","volume":"274","author":"Daigo","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2023.114967_b0365","doi-asserted-by":"crossref","unstructured":"C. Garianda, E. Hirsch, S. Bozza, A. Salustri, M. De Acetis, R. Nota, A. Maccagno, F. Riva, B. Bottazzi, G. Peri, A. Doni, L. Vago, M. Botto, R. De Santis, P. Carminati, G. Siracusa, F. Altruda, A. Vecchi, L. Romani, A. Mantovani, Non-redundant role of the long pentraxin PTX3 in anti-fungal innate immune response, Nat. 420 (2002) 182\u2013186, doi: 10.1038\/nature01195.","DOI":"10.1038\/nature01195"},{"key":"10.1016\/j.addr.2023.114967_b0370","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.chom.2012.04.005","article-title":"Dendritic cells in antifungal immunity and vaccine design","volume":"11","author":"Roy","year":"2012","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.addr.2023.114967_b0375","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1023\/B:VERC.0000046743.27552.19","article-title":"DNA fragment encoding human IL-1\u03b2 163\u2013171 peptide enhances the immune responses elicited in mice by DNA vaccine against foot-and-mouth disease","volume":"29","author":"Shao","year":"2005","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.addr.2023.114967_b0380","doi-asserted-by":"crossref","first-page":"3807","DOI":"10.1182\/blood-2003-03-0748","article-title":"A dendritic cell vaccine against invasive aspergillosis in allogeneic hematopoietic transplantation","volume":"102","author":"Bozza","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.addr.2023.114967_b0385","doi-asserted-by":"crossref","first-page":"10455","DOI":"10.1074\/jbc.M412592200","article-title":"N-cadherin mediates endocytosis of Candida albicans by endothelial cells","volume":"280","author":"Phan","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.114967_b0390","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.micinf.2005.07.027","article-title":"Glucuronoxylomannan-mediated interaction of Cryptococcus neoformans with human alveolar cells results in fungal internalization and host cell damage","volume":"8","author":"Barbosa","year":"2006","journal-title":"Microbes Infect."},{"key":"10.1016\/j.addr.2023.114967_b0395","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12866-014-0211-9","article-title":"Evidence of involvement of the mannose receptor in the internalization of Streptococcus pneumoniae by Schwann cells","volume":"14","author":"Macedo-Ramos","year":"2014","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0400","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1128\/IAI.00480-10","article-title":"Development and validation of an in vivo Candida albicans biofilm denture model","volume":"78","author":"Nett","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2023.114967_b0405","doi-asserted-by":"crossref","first-page":"918","DOI":"10.3390\/pharmaceutics12100918","article-title":"In vitro activity of carbosilane cationic dendritic molecules on prevention and treatment of Candida albicans biofilms","volume":"12","author":"Heredero-Bermejo","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.addr.2023.114967_b0410","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.202000537","article-title":"Antifungal-inbuilt metal\u2013organic-frameworks eradicate Candida albicans biofilms","volume":"30","author":"Su","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0415","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.addr.2019.08.006","article-title":"Hyaluronan as tunable drug delivery system","volume":"146","author":"Passi","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2023.114967_b0420","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/2211550105666160213002658","article-title":"Discovery and characteristic of hyaluronidases from filamentous fungi","volume":"7","author":"Bobkova","year":"2016","journal-title":"Curr. Biotechnol."},{"key":"10.1016\/j.addr.2023.114967_b0425","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.biomaterials.2014.10.065","article-title":"Hyaluronic acid-modified Fe3O4@Au core\/shell nanostars for multimodal imaging and photothermal therapy of tumors","volume":"38","author":"Li","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114967_b0430","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1002\/smll.201601729","article-title":"Bacterial Hyaluronidase self-triggered prodrug release for chemo-photothermal synergistic treatment of bacterial infection","volume":"12","author":"Ji","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.addr.2023.114967_b0435","doi-asserted-by":"crossref","unstructured":"A.K. Singh, M. Mukhopadhyay, Overview of fungal lipase: a review, Appl. Biochem. Biotechnol. 166 (2011) 486\u2013520, doi: 10.1007\/S12010-011-9444-3.","DOI":"10.1007\/s12010-011-9444-3"},{"key":"10.1016\/j.addr.2023.114967_b0440","doi-asserted-by":"crossref","first-page":"15145","DOI":"10.1039\/C9CC08463K","article-title":"A lipase-responsive antifungal nanoplatform for synergistic photodynamic\/photothermal\/pharmaco-therapy of azole-resistant Candida albicans infections","volume":"55","author":"Yang","year":"2019","journal-title":"Chem. Commun."},{"key":"10.1016\/j.addr.2023.114967_b0445","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1051\/medsci\/20143005015","article-title":"Lp-PLA2 and sPLA2: cardiovascular biomarkers","volume":"30","author":"Ait-Oufella","year":"2014","journal-title":"Med. Sci. (Paris)"},{"key":"10.1016\/j.addr.2023.114967_b0450","doi-asserted-by":"crossref","first-page":"30676","DOI":"10.1074\/jbc.M110.143800","article-title":"Pathways regulating cytosolic phospholipase A2 activation and eicosanoid production in macrophages by Candida albicans","volume":"285","author":"Suram","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2023.114967_b0455","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/156720105774370203","article-title":"Triggered activation and release of liposomal prodrugs and drugs in cancer tissue by secretory phospholipase A2","volume":"2","author":"Andresen","year":"2005","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.addr.2023.114967_b0460","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1021\/jm031029r","article-title":"Enzymatic release of antitumor ether lipids by specific phospholipase A 2 activation of liposome-forming prodrugs","volume":"47","author":"Andresen","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.addr.2023.114967_b0465","doi-asserted-by":"crossref","first-page":"3220","DOI":"10.1016\/j.apsb.2021.04.020","article-title":"Bioresponsive micro-to-nano albumin-based systems for targeted drug delivery against complex fungal infections","volume":"11","author":"Cheng","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2023.114967_b0470","doi-asserted-by":"crossref","first-page":"S120","DOI":"10.3109\/13693786.2010.495139","article-title":"Implications of hypoxic microenvironments during invasive aspergillosis","volume":"49","author":"Wezensky","year":"2011","journal-title":"Med. Mycol."},{"key":"10.1016\/j.addr.2023.114967_b0475","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0076-6879(07)35021-0","article-title":"Regulation of hypoxia-inducible factors during inflammation","volume":"435","author":"Frede","year":"2007","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.addr.2023.114967_b0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002145","article-title":"In vivo hypoxia and a fungal alcohol dehydrogenase influence the pathogenesis of invasive pulmonary Aspergillosis","volume":"7","author":"Grahl","year":"2011","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.addr.2023.114967_b0485","doi-asserted-by":"crossref","first-page":"7023","DOI":"10.1128\/AEM.01288-08","article-title":"Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive Aspergillosis","volume":"74","author":"Brock","year":"2008","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0490","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1002\/adma.201204455","article-title":"Highly discriminating photorelease of anticancer drugs based on hypoxia activatable phototrigger conjugated chitosan nanoparticles","volume":"25","author":"Qiuning Lin","year":"2013","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0495","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S1286-4579(02)00024-2","article-title":"Metabolites released by Cryptococcus neoformans var. neoformans and var. gattii differentially affect human neutrophil function","volume":"4","author":"Wright","year":"2002","journal-title":"Microbes Infect."},{"key":"10.1016\/j.addr.2023.114967_b0500","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1002\/(SICI)1522-2594(199909)42:3<442::AID-MRM6>3.0.CO;2-Q","article-title":"Heteronuclear NMR studies of metabolites produced byCryptococcus neoformans in culture media: identification of possible virulence factors","volume":"42","author":"Bubb","year":"1999","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.addr.2023.114967_b0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.onano.2021.100031","article-title":"Advances in pH-responsive drug delivery systems","volume":"5","author":"Mu","year":"2021","journal-title":"OpenNano."},{"key":"10.1016\/j.addr.2023.114967_b0510","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.1021\/acs.chemmater.6b02896","article-title":"Acid-responsive polymeric doxorubicin prodrug nanoparticles encapsulating a near-infrared dye for combined photothermal-chemotherapy","volume":"28","author":"Zhang","year":"2016","journal-title":"Chem. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0515","doi-asserted-by":"crossref","first-page":"14746","DOI":"10.1021\/ja5042429","article-title":"pH and amphiphilic structure direct supramolecular behavior in biofunctional assemblies","volume":"136","author":"Moyer","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.addr.2023.114967_b0520","article-title":"Host materials transformable in tumor microenvironment for homing theranostics","volume":"29","author":"Yang","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.addr.2023.114967_b0525","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1039\/C9TB02586C","article-title":"pH-Responsive copolymer micelles to enhance itraconazole efficacy against Candida albicans biofilms","volume":"8","author":"Albayaty","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2023.114967_b0530","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1080\/10717544.2022.2037788","article-title":"Effect of pH-sensitive nanoparticles on inhibiting oral biofilms","volume":"29","author":"Peng","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.addr.2023.114967_b0535","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.tim.2011.07.004","article-title":"Importance of Candida\u2013bacterial polymicrobial biofilms in disease","volume":"19","author":"Harriott","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0540","doi-asserted-by":"crossref","unstructured":"W. Kr\u00fcger, S. Vielreicher, M. Kapitan, I.D. Jacobsen, M.J. Niemiec, Fungal-bacterial interactions in health and disease, Pathog. 8 (2019) 70, doi: 10.3390\/PATHOGENS8020070.","DOI":"10.3390\/pathogens8020070"},{"key":"10.1016\/j.addr.2023.114967_b0545","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01365-16","article-title":"Commensal protection of Staphylococcus aureus against antimicrobials by Candida albicans Biofilm Matrix","volume":"7","author":"Kong","year":"2016","journal-title":"MBio"},{"key":"10.1016\/j.addr.2023.114967_b0550","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3389\/fcimb.2020.624839","article-title":"Adhesion of Staphylococcus aureus to Candida albicans during co-infection promotes bacterial dissemination through the host immune response","volume":"10","author":"Van Dyck","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0555","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1128\/IAI.00265-13","article-title":"Candida albicans-Staphylococcus aureus polymicrobial peritonitis modulates host innate immunity","volume":"81","author":"Peters","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2023.114967_b0560","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0135404","article-title":"Prostaglandin E2 from Candida albicans stimulates the growth of Staphylococcus aureus in mixed biofilms","volume":"10","author":"Krause","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2023.114967_b0565","doi-asserted-by":"crossref","first-page":"e1007342","DOI":"10.1371\/journal.ppat.1007342","article-title":"Candida\u2013streptococcal interactions in biofilm-associated oral diseases","volume":"14","author":"Koo","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.addr.2023.114967_b0570","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1128\/IAI.00685-10","article-title":"Interaction of Candida albicans cell wall Als3 protein with Streptococcus gordonii SspB adhesin promotes development of mixed-species communities","volume":"78","author":"Silverman","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2023.114967_b0575","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3389\/fcimb.2022.940602","article-title":"Streptococcus mutans membrane vesicles enhance Candida albicans pathogenicity and carbohydrate metabolism","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0580","doi-asserted-by":"crossref","first-page":"643","DOI":"10.13005\/bpj\/2403","article-title":"Review of known and unknown facts of Klebsiella pneumoniae and its relationship with antibiotics","volume":"15","author":"Pavan","year":"2022","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.addr.2023.114967_b0585","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1128\/AEM.72.2.1542-1550.2006","article-title":"Induction by Klebsiella aerogenes of a melanin-like pigment in Cryptococcus neoformans","volume":"72","author":"Frases","year":"2006","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0590","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tim.2009.06.006","article-title":"Color me bad: microbial pigments as virulence factors","volume":"17","author":"Liu","year":"2009","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0595","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.2174\/138161207782794220","article-title":"From drug target to leads-sketching A physicochemical pathway for lead molecule design in silico","volume":"13","author":"Shaikh","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.addr.2023.114967_b0600","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/978-981-16-5180-9_21","article-title":"Bioinformatics in drug design and delivery","author":"Kumar","year":"2022","journal-title":"Comput. Aided Pharm. Drug Deliv."},{"key":"10.1016\/j.addr.2023.114967_b0605","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1476-5381.2010.01127.x","article-title":"Principles of early drug discovery","volume":"162","author":"Hughes","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.addr.2023.114967_b0610","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1002\/pmic.200800597","article-title":"Membrane proteins and membrane proteomics","volume":"8","author":"Tan","year":"2008","journal-title":"Proteomics"},{"key":"10.1016\/j.addr.2023.114967_b0615","doi-asserted-by":"crossref","first-page":"3385","DOI":"10.1021\/pr060372s","article-title":"Global comparison of the membrane subproteomes between a multidrug-resistant Acinetobacter baumannii strain and a reference strain","volume":"5","author":"Siroy","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.addr.2023.114967_b0620","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1002\/pmic.200500323","article-title":"Proteomic analysis of a fraction enriched in cell envelope proteins of Acinetobacter baumannii","volume":"6","author":"Mart\u00ed","year":"2006","journal-title":"Proteomics"},{"key":"10.1016\/j.addr.2023.114967_b0625","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijmm.2014.12.017","article-title":"Global analysis of bacterial membrane proteins and their modifications","volume":"305","author":"Soufi","year":"2015","journal-title":"Int. J. Med. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2020.113840","article-title":"The status of proteomics as we enter the 2020s: towards personalised\/precision medicine","volume":"644","author":"Nice","year":"2022","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.addr.2023.114967_b0635","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1128\/AAC.00756-09","article-title":"Changes in the proteome of Candida albicans in response to azole, polyene, and echinocandin antifungal agents","volume":"54","author":"Hoehamer","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.addr.2023.114967_b0640","doi-asserted-by":"crossref","unstructured":"J.N.Y. Chan, D. Vuckovic, L. Sleno, J.B. Olsen, O. Pogoutse, P. Havugimana, J.A. Hewel, N. Bajaj, Y. Wang, M.F. Musteata, C. Nislow, A. Emili, Target identification by chromatographic co-elution: monitoring of drug-protein interactions without immobilization or chemical derivatization, Mol. Cell. Proteomics. 11 (2012) M111.016642-1, doi: 10.1074\/mcp.M111.016642.","DOI":"10.1074\/mcp.M111.016642"},{"key":"10.1016\/j.addr.2023.114967_b0645","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1003733","article-title":"Analysis of the protein domain and domain architecture content in fungi and its application in the search of new antifungal targets","volume":"10","author":"Barrera","year":"2014","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.addr.2023.114967_b0650","doi-asserted-by":"crossref","unstructured":"K.D. Mandakhalikar, Medical biofilms, in: ACS Symp. Ser., American Chemical Society, 2019, pp. 83\u201399, doi: 10.1021\/bk-2019-1323.ch004.","DOI":"10.1021\/bk-2019-1323.ch004"},{"key":"10.1016\/j.addr.2023.114967_b0655","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/1040841X.2021.1950121","article-title":"Biofilm formation in clinically relevant filamentous fungi: a therapeutic challenge","volume":"48","author":"Roudbary","year":"2021","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.addr.2023.114967_b0660","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017046","article-title":"From attachment to damage: defined genes of Candida albicans mediate adhesion, invasion and damage during interaction with oral epithelial cells","volume":"6","author":"W\u00e4chtler","year":"2011","journal-title":"PLoS ONE."},{"key":"10.1016\/j.addr.2023.114967_b0665","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/EC.00279-10","article-title":"Candida albicans Als3, a multifunctional adhesin and invasin","volume":"10","author":"Liu","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.addr.2023.114967_b0670","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00915-18","article-title":"Candida albicans-induced epithelial damage mediates translocation through intestinal barriers","volume":"9","author":"Allert","year":"2018","journal-title":"MBio"},{"key":"10.1016\/j.addr.2023.114967_b0675","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006452","article-title":"Functional genomic analysis of Candida albicans adherence reveals a key role for the Arp2\/3 complex in cell wall remodelling and biofilm formation","volume":"12","author":"Lee","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.addr.2023.114967_b0680","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s12551-016-0247-1","article-title":"Software for molecular docking: a review","volume":"9","author":"Pagadala","year":"2017","journal-title":"Biophys. Rev."},{"key":"10.1016\/j.addr.2023.114967_b0685","doi-asserted-by":"crossref","unstructured":"J. Kim, K.T. Lee, J.S. Lee, J. Shin, B. Cui, K. Yang, Y.S. Choi, N. Choi, S.H. Lee, J.H. Lee, Y.S. Bahn, S.W. Cho, Fungal brain infection modelled in a human-neurovascular-unit-on-a-chip with a functional blood\u2013brain barrier, Nat. Biomed. Eng. 5 (2021) 830\u2013846, doi: 10.1038\/s41551-021-00743-8.","DOI":"10.1038\/s41551-021-00743-8"},{"key":"10.1016\/j.addr.2023.114967_b0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.115057","article-title":"Integrated technologies for continuous monitoring of organs-on-chips: current challenges and potential solutions","volume":"224","author":"Sabat\u00e9 del R\u00edo","year":"2023","journal-title":"Biosens. Bioelectron."},{"key":"10.1016\/j.addr.2023.114967_b0695","doi-asserted-by":"crossref","first-page":"12737","DOI":"10.1038\/s41598-017-13070-3","article-title":"Organs on chip approach: a tool to evaluate cancer -immune cells interactions","volume":"7","author":"Biselli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2023.114967_b0700","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.drudis.2018.10.003","article-title":"Towards the development of human immune-system-on-a-chip platforms","volume":"24","author":"Polini","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2023.114967_b0705","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/imm.12972","article-title":"A complex interplay between the extracellular matrix and the innate immune response to microbial pathogens","volume":"155","author":"Tomlin","year":"2018","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2023.114967_b0710","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.01020-20","article-title":"Fun(gi)omics: advanced and diverse technologies to explore emerging fungal pathogens and define mechanisms of antifungal resistance","volume":"11","author":"Ball","year":"2020","journal-title":"MBio"},{"key":"10.1016\/j.addr.2023.114967_b0715","doi-asserted-by":"crossref","unstructured":"W.N. Lin, M.Z. Tay, R. Lu, Y. Liu, C.H. Chen, L.F. Cheow, The Role of single-cell technology in the study and control of infectious diseases, Cells 9 (2020) 1440, doi: 10.3390\/CELLS9061440.","DOI":"10.3390\/cells9061440"},{"key":"10.1016\/j.addr.2023.114967_b0720","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1016\/j.biomaterials.2012.07.046","article-title":"Anti-glioblastoma efficacy and safety of paclitaxel-loading Angiopep-conjugated dual targeting PEG-PCL nanoparticles","volume":"33","author":"Xin","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114967_b0725","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.biomaterials.2011.02.044","article-title":"Angiopep-conjugated poly(ethylene glycol)-co-poly(\u03b5-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma","volume":"32","author":"Xin","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2023.114967_b0730","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the horizon: novel fungal treatments in development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.addr.2023.114967_b0735","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopha.2018.12.009","article-title":"Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases","volume":"110","author":"Nami","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2023.114967_b0740","doi-asserted-by":"crossref","unstructured":"D.J. Irvine, M.A. Swartz, G.L. Szeto, Engineering synthetic vaccines using cues from natural immunity, Nat. Mater. 12 (2013) 978\u2013990, doi: 10.1038\/nmat3775.","DOI":"10.1038\/nmat3775"},{"key":"10.1016\/j.addr.2023.114967_b0745","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2174\/2211738507666191024162042","article-title":"Nanoparticles and vaccine development","volume":"8","author":"Kheirollahpour","year":"2020","journal-title":"Pharm. Nanotechnol."},{"key":"10.1016\/j.addr.2023.114967_b0750","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1021\/nl504798g","article-title":"Modulating antibacterial immunity via bacterial membrane-coated nanoparticles","volume":"15","author":"Gao","year":"2015","journal-title":"Nano Lett."},{"key":"10.1016\/j.addr.2023.114967_b0755","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1128\/IAI.01171-09","article-title":"Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions","volume":"78","author":"Oliveira","year":"2010","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2023.114967_b0760","doi-asserted-by":"crossref","unstructured":"J.A.M. Souza, L. de M. Baltazar, V.M. Carregal, L. Gouveia-Eufrasio, A.G. de Oliveira, W.G. Dias, M. Campos Rocha, K. Rocha de Miranda, I. Malavazi, D. de A. Santos, F.J.G. Fr\u00e9zard, D. da G. de Souza, M.M. Teixeira, F.M. Soriani, Characterization of Aspergillus fumigatus extracellular vesicles and their effects on macrophages and neutrophils functions, Front. Microbiol. 10 (2019) 2008, doi: 10.3389\/fmicb.2019.02008.","DOI":"10.3389\/fmicb.2019.02008"},{"key":"10.1016\/j.addr.2023.114967_b0765","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41467-018-03991-6","article-title":"Pathogen-derived extracellular vesicles mediate virulence in the fatal human pathogen Cryptococcus gattii","volume":"9","author":"Bielska","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2023.114967_b0770","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jim.2014.03.022","article-title":"Overview of vertebrate animal models of fungal infection","volume":"410","author":"Hohl","year":"2014","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.addr.2023.114967_b0775","doi-asserted-by":"crossref","unstructured":"C. Faustino, L. Pinheiro, Lipid systems for the delivery of amphotericin B in antifungal therapy, Pharm. 12 (2020) 29, doi: 10.3390\/PHARMACEUTICS12010029.","DOI":"10.3390\/pharmaceutics12010029"},{"key":"10.1016\/j.addr.2023.114967_b0780","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.apsb.2021.04.010","article-title":"Delivery strategies of amphotericin B for invasive fungal infections","volume":"11","author":"Wang","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2023.114967_b0785","first-page":"575","article-title":"Current challenges and future directions in nanomedicine","author":"Das Mandal","year":"2021","journal-title":"Emerg. Technol. Nanoparticle Manuf."},{"key":"10.1016\/j.addr.2023.114967_b0790","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110302","article-title":"Grand challenges in nanomedicine","volume":"106","author":"Wu","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.addr.2023.114967_b0795","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1039\/C8CS00787J","article-title":"Stimuli-responsive self-assembly of nanoparticles","volume":"48","author":"Grzelczak","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.addr.2023.114967_b0800","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1039\/C9TB00557A","article-title":"Recent advances in gold nanoparticles for biomedical applications: from hybrid structures to multi-functionality","volume":"7","author":"Jeong","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.addr.2023.114967_b0805","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11051-017-3875-x","article-title":"Price tag in nanomaterials?","volume":"19","author":"Gkika","year":"2017","journal-title":"J. Nanoparticle Res."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2300282X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X2300282X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:46:34Z","timestamp":1759211194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X2300282X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":161,"alternative-id":["S0169409X2300282X"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2023.114967","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antifungal therapy: Novel drug delivery strategies driven by new targets","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2023.114967","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114967"}}